Circulating non-coding RNAs in biomarker-guided cardiovascular therapy: a novel tool for personalized medicine?

D de Gonzalo-Calvo, A Vea, C Bär… - European Heart …, 2019 - academic.oup.com
… subgroups of patients, to receive precision medical care. … individualized treatment has gained
attention in recent years. Indeed, drug-diagnostic co-development (‘companion diagnostics’…

More than the sum of the respiratory events: personalized medicine approaches for obstructive sleep apnea

BA Edwards, S Redline, SA Sands… - … critical care medicine, 2019 - atsjournals.org
… if they directly result in cardiovascular disease independent of breathing disturbances or are
a consequence of another process, such as subclinical renal dysfunction, which itself might …

Genomic profiling in renal cell carcinoma

N Dizman, EJ Philip, SK Pal - Nature Reviews Nephrology, 2020 - nature.com
… of precision medicine … , new insights into the mechanisms that underlie the development
and progression of RCC have expanded treatment options; genomic data might guide treatment

Organoid based personalized medicine: from bench to bedside

Y Li, P Tang, S Cai, J Peng, G Hua - Cell Regeneration, 2020 - Springer
… cystic fibrosis have great value for drug development and personalized medicine. In addition,
organoids hold promise for regenerative medicine. In the present review, we discuss the …

Patients' and professionals' views related to ethical issues in precision medicine: a mixed research synthesis

A Erdmann, C Rehmann-Sutter, C Bozzaro - BMC medical ethics, 2021 - Springer
… also the case with precision medicine and personalized medicine, it seems … precision
medicine and personalized medicine have gained more popularity than the term systems medicine

Genetics, dyslipidemia, and cardiovascular disease: new insights

R Stein, F Ferrari, F Scolari - Current cardiology reports, 2019 - Springer
… for treatment. Finally, we examine how precision medicine, specifically genetic testing and
… -generation sequencing (NGS), is advancing knowledge on dyslipidemia and CV disease. …

[HTML][HTML] How close are miRNAs from clinical practice? A perspective on the diagnostic and therapeutic market

E Bonneau, B Neveu, E Kostantin, GJ Tsongalis… - Ejifcc, 2019 - ncbi.nlm.nih.gov
… To address this question, we reviewed the miRNA diagnostic and therapeutic market. With
many companies developing miRNA panels, the activity is high in the diagnostic area. Some …

Molluscum contagiosum: an update and review of new perspectives in etiology, diagnosis, and treatment

R Meza-Romero, C Navarrete-Dechent… - Clinical, cosmetic and …, 2019 - Taylor & Francis
treatment for MC is controversial; however, there is a consensus that it should be indicated in
cases of extensive disease… manifestations, diagnosis, and management alternatives of MC. …

Screening for diabetic retinopathy: new perspectives and challenges

S Vujosevic, SJ Aldington, P Silva… - The Lancet Diabetes & …, 2020 - thelancet.com
… cases that need timely full ophthalmic examination and treatment to avoid permanent visual
loss. In the past few years, personalised screening intervals that take into account several …

Polygenic risk scores in the clinic: new perspectives needed on familiar ethical issues

ACF Lewis, RC Green - Genome Medicine, 2021 - Springer
… The concept of a disease It is part of the hope of precision medicine that disease classification
is refined. In this vision, the broad definitions we have of conditions, based on symptoms …